Enalapril - CAS 75847-73-3
Catalog: |
BB035417 |
Product Name: |
Enalapril |
CAS: |
75847-73-3 |
Synonyms: |
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
Application: |
Enalapril is used in the treatment of hypertension, congestive heart failure, myocardial infarction, and diabetic nephropathies. lt decreases levels of angiotensin II leading to less vasoconstriction and decreased blood pressure by inhibiting ACE. lt lowers the death rate in systolic heart failure. |
Related CAS: | 76095-16-4 (Maleate)
|
IUPAC Name: | (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid |
Description: | Enalapril is an angiotensin converting enzyme (ACE) inhibitor used in the treatment of hypertension, congestive heart failure, myocardial infarction, and diabetic nephropathies. Its IC50 values range from 2 to 800 nM. lt belongs to a class of medications called angiotensin converting enzyme inhibitors. pressure. lt decreases levels of angiotensin II leading to less vasoconstriction and decreased blood pressure by inhibiting ACE. lt has been shown to lower the death rate in systolic heart failure. It is on the World Health Organization's List of Essential Medicines, the most important medications needed in a basic health system. |
Molecular Weight: | 376.45 |
Molecular Formula: | C20H28N2O5 |
Canonical SMILES: | CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O |
InChI: | InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1 |
InChI Key: | GBXSMTUPTTWBMN-XIRDDKMYSA-N |
Boiling Point: | 582.4±50.0 °C | Condition: Press: 760 Torr |
Melting Point: | 143-144 °C |
Purity: | 98 % |
Density: | 1.204±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr |
Solubility: | DMSO 99 mg/mL; Water <1 mg/Ml |
Appearance: | White needle like crystal or crystalline powder |
Storage: | -20 °C Freezer |
LogP: | 1.93340 |
Quality Standard: | In-house standard |
Stability: | Stable under recommended storage conditions. /enalapril maleate/ |
Vapor Pressure: | 1.06X10-12 mm Hg at 25 °C (est) |
GHS Hazard Statement: | H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] |
Precautionary Statement: | P201, P202, P261, P272, P280, P281, P302+P352, P308+P313, P321, P333+P313, P363, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113480597-A | ACE inhibitory peptide derived from perilla seed meal as well as preparation method and application thereof | 20210729 |
CN-113181332-A | Medicine for treating heart failure and preparation method thereof | 20210604 |
CN-113324933-A | Method for detecting angiotensin converting enzyme and application thereof | 20210601 |
CN-113321719-A | Oligopeptide, and preparation method and application thereof | 20210520 |
CN-113288906-A | Composition containing adriamycin and application thereof | 20210519 |
PMID | Publication Date | Title | Journal |
31887396 | 20200201 | Egr1/p300/ACE signal mediates postnatal osteopenia in female rat offspring induced by prenatal ethanol exposure | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association |
31306001 | 20190808 | Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity | Journal of medicinal chemistry |
30940551 | 20190701 | Exposure to diisononyl phthalate induced an increase in blood pressure through activation of the ACE/ AT1R axis and inhibition of NO production | Toxicology letters |
31165171 | 20190604 | Investigations on the Relationship between Ovarian, Endocrine, and Renal Findings in Nonclinical Safety Studies of the γ-secretase Inhibitor Avagacestat | Toxicological sciences : an official journal of the Society of Toxicology |
30623541 | 20190501 | Hesperidin regresses cardiac hypertrophy by virtue of PPAR-γ agonistic, anti-inflammatory, antiapoptotic, and antioxidant properties | Journal of biochemical and molecular toxicology |
Complexity: | 519 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 3 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 376.19982200 |
Formal Charge: | 0 |
Heavy Atom Count: | 27 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 376.19982200 |
Rotatable Bond Count: | 10 |
Topological Polar Surface Area: | 95.9 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyrrolidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS